John Robert Porter

USPTO Granted Patents = 66 (Patent Applications = 3)

CIPO Patents = 19 (Patent Applications = 4)

EPO Patents = 22 (Patent Applications = 29)

Average Co-Inventor Count = 5.0

ph-index = 10

Forward Citations = 368(Granted Patents)

Forward Citations (Not Self Cited) = 305(Oct 12, 2025)

Inventors with similar research interests:

Location History:

Berkshire, GB (1996)
Maidenhead, GB (2002)
Chinnor, GB (1997 - 2011)
Oxfordshire, GB (2003 - 2015)
Slough Berkshire, GB (2020)
Slough, GB (1994 - 2024)

Company Filing History:

Celltech Therapeutics Limited

where one patent can have more than one assignee

Years Active: 1994-2024

Loading Chart...

66 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12055549 - Methods of use of anti-TNFα antibodies (2024-08-06),

2. 11674967 - Method of identifying potential inhibitors of APO TNFα trimers (2023-06-13),

3. 11448655 - Method for identifying a modulator of the TNFα or CD40L interaction with their cognate receptors (2022-09-20),

4. 11174311 - Antibody against trimeric TNFα complex (2021-11-16),

5. 11022614 - Antibodies binding to trimeric TNF alpha epitopes (2021-06-01),

6. 10969393 - Complexes between anti-TNF antibodies, trimeric TNF proteins and organic molecules binding them (2021-04-06),

7. 10883996 - Methods of identifying signaling modulators of the trimeric TNFa (2021-01-05),

8. 10775385 - Treatment of autoimmune and inflammatory disorders with asymmetric TNF alpha trimers (2020-09-15),

9. 10705094 - TNF receptor signaling modulator assay (2020-07-07),

10. 10287299 - Substituted benzo[b][1,4]oxazines and pyrido[3,2-b][1,4]oxazines as modulators of tumor necrosis factor activity (2019-05-14),

11. 10093652 - Tetrahydrobenzimidazole derivatives as modulators of TNF activity (2018-10-09),

12. 9988383 - Purine derivatives as modulators of TNF activity (2018-06-05),

13. 9969729 - Imidazopyridine derivatives as modulators of TNF activity (2018-05-15),

14. 9969728 - Tetrahydroimidazopyridine derivatives as modulators of TNF activity (2018-05-15),

15. 9932342 - Imidazopyrimidine derivatives as modulators of TNF activity (2018-04-03),

Title: John Robert Porter: A Trailblazer in Innovation

Introduction:

John Robert Porter, an esteemed inventor based in Slough, GB, has earned recognition for his relentless dedication to pushing the boundaries of what is possible through innovation. With a remarkable portfolio of 65 patents, his impact in the field of biopharmaceuticals and molecular biology is set to be felt for years to come.

Latest Patents:

1. Method of identifying potential inhibitors of APO TNFα trimers: Porter's groundbreaking patent introduces a new, stable trimeric TNFα structure with distorted symmetry. This innovative structure can bind to the TNFR1 receptor to attenuate signaling, promising advancements in the treatment and prevention of diseases associated with the soluble TNFα/TNFR1 interaction.

2. Method for identifying a modulator of the TNFα or CD40L interaction with their cognate receptors: Porter's patent reveals specific compounds that bind to TNFα and stabilize a conformation of trimeric TNF. These compounds serve as modulators of TNF, with a new assay for identifying similar compounds with the same mechanism of action.

Career Highlights:

Throughout his illustrious career, John Robert Porter has made significant contributions while working at reputable companies such as Celltech R&D Limited and UCB Biopharma SPRL. His innovative approach and trailblazing spirit have set him apart as a true pioneer in the field.

Collaborations:

Porter has collaborated with esteemed professionals like John Clifford Head and Graham John Warrellow, showcasing his ability to work synergistically with like-minded visionaries in the industry. These collaborations have led to groundbreaking research and the development of novel therapies.

Conclusion:

In conclusion, John Robert Porter's unwavering commitment to innovation and his groundbreaking contributions to the field of biopharmaceuticals highlight him as a true trailblazer. His patents and collaborative efforts stand as a testament to his dedication to advancing science and improving lives through transformative discoveries. John Robert Porter's legacy as a pioneering inventor is sure to inspire future generations in the realm of scientific innovation.

This text is generated by artificial intelligence and may not be accurate.